Total Payments
$14,970
2024 Payments
$2,691
Companies
53
Transactions
773
Medicare Patients
2,584
Medicare Billing
$152,884
Payment Breakdown by Category
Food & Beverage$14,808 (98.9%)
Education$162.72 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,808 | 764 | 98.9% |
| Education | $162.72 | 9 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,534 | 96 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,303 | 50 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,147 | 40 | $0 (2024) |
| Novo Nordisk Inc | $1,089 | 80 | $0 (2024) |
| Amgen Inc. | $1,055 | 60 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $989.89 | 6 | $0 (2024) |
| PFIZER INC. | $892.51 | 63 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $740.55 | 31 | $0 (2024) |
| Lilly USA, LLC | $644.23 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $568.01 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,691 | 110 | AIMMUNE THERAPEUTICS, INC. ($989.89) |
| 2023 | $1,933 | 119 | ABBVIE INC. ($388.23) |
| 2022 | $1,870 | 131 | ABBVIE INC. ($390.69) |
| 2021 | $791.68 | 57 | AbbVie Inc. ($187.31) |
| 2019 | $131.60 | 11 | Novo Nordisk Inc ($23.94) |
| 2018 | $1,773 | 92 | Amgen Inc. ($217.57) |
| 2017 | $5,781 | 253 | SANOFI-AVENTIS U.S. LLC ($935.84) |
All Payment Transactions
773 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $23.12 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.82 | General |
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: PAIN | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: PAIN | ||||||
| 10/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $34.68 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: VIROLOGY | ||||||
| 10/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: VIROLOGY | ||||||
| 10/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: VACCINES | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 846 | 1,182 | $237,926 | $56,608 |
| 2022 | 15 | 859 | 1,209 | $141,864 | $48,372 |
| 2021 | 10 | 604 | 712 | $101,070 | $36,021 |
| 2020 | 4 | 275 | 291 | $44,432 | $11,883 |
Total Patients
2,584
Total Services
3,394
Medicare Billing
$152,884
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 297 | $107,811 | $23,733 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 371 | $94,976 | $19,987 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $14,880 | $4,796 | 32.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $6,175 | $1,994 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 160 | 256 | $1,792 | $1,751 | 97.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,386 | $1,358 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,082 | $983.34 | 24.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 23 | $805.00 | $657.11 | 81.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 47 | $3,194 | $639.28 | 20.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 39 | $1,560 | $369.25 | 23.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 25 | $1,025 | $250.53 | 24.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 40 | $240.00 | $88.00 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 311 | 428 | $67,624 | $22,447 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 230 | $53,360 | $18,852 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $3,720 | $1,845 | 49.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $6,870 | $1,112 | 16.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $1,320 | $753.94 | 57.1% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 17 | 17 | $833.00 | $623.19 | 74.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 35 | 35 | $2,238 | $571.57 | 25.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 127 | 191 | $1,337 | $562.22 | 42.1% |
| 85610 | Blood test, clotting time | Office | 2022 | 15 | 98 | $980.00 | $415.79 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $525.00 | $410.70 | 78.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 36 | $1,728 | $348.68 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 17 | $595.00 | $139.47 | 23.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 47 | 57 | $342.00 | $126.49 | 37.0% |
About Dr. Barclay Monaster, MD
Dr. Barclay Monaster, MD is a Family Medicine healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962418640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barclay Monaster, MD has received a total of $14,970 in payments from pharmaceutical and medical device companies, with $2,691 received in 2024. These payments were reported across 773 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,808).
As a Medicare-enrolled provider, Monaster has provided services to 2,584 Medicare beneficiaries, totaling 3,394 services with total Medicare billing of $152,884. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Council Bluffs, IA
- Active Since 08/01/2006
- Last Updated 10/15/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1962418640
Products in Payments
- ELIQUIS (Drug) $684.26
- ZENPEP (Drug) $672.86
- FARXIGA (Drug) $600.60
- VOWST (Biological) $475.65
- XARELTO (Drug) $470.52
- QULIPTA (Drug) $458.51
- TRULICITY (Drug) $456.88
- Prolia (Biological) $426.06
- Kerendia (Drug) $408.45
- UBRELVY (Drug) $387.80
- SOLIQUA (Drug) $344.08
- ENTRESTO (Drug) $343.92
- Ozempic (Drug) $319.13
- JARDIANCE (Drug) $316.26
- DIABETES - DISEASE (Drug) $295.61
- TOUJEO (Drug) $294.81
- Victoza (Drug) $279.90
- Myrbetriq (Drug) $274.30
- EVENITY (Biological) $267.03
- INVOKANA (Drug) $264.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Council Bluffs
Kevin Sheppard, M.d, M.D
Family Medicine — Payments: $30,467
Family Medicine $30,467
James Whalen, M.d, M.D
Family Medicine — Payments: $23,126
Family Medicine $23,126
Dr. Mel Roca, M.d, M.D
Family Medicine — Payments: $14,262
Family Medicine $14,262
Dr. Kavish Rohatgi, Mbbs, MBBS
Family Medicine — Payments: $13,262
Family Medicine $13,262
Joseph Wanzek, D.o, D.O
Family Medicine — Payments: $12,109
Family Medicine $12,109
Krista Hill, M.d, M.D
Family Medicine — Payments: $9,765
Family Medicine $9,765